On-Demand Webinars

  1. Beyond CRISPR: Next-Gen Gene Editing With TARGATT, Mad7, Base Editing 1/17/2025

    Consider several gene editing technologies — TARGATT, Mad7, and Base Editing — and gain insights into their transformative applications in genetic engineering and therapeutic development.

  2. The Future Of Allogeneic Cell Therapy: Hypoimmunogenic Donor Cells 1/17/2025

    Explore how TARGATT® gene editing and HLA-F technologies are revolutionizing hypoimmunogenic cell development for scalable allogeneic therapies.

  3. Growing A Sustainability Culture Across An Expanding CDMO Network 1/15/2025

    Peter Skals, Head of Global Sustainability, shares how the company is integrating its climate and ESG strategy while simultaneously expanding its CDMO network and reducing its CO2 footprint.

  4. Revolutionizing Bioanalysis: Harnessing AI For Enhanced Precision, Insights, And Efficiency 1/14/2025

    Can AI predict immunotherapy success earlier than traditional methods? Experts reveal data-backed applications in this enlightening session.

  5. How To Prevent Protein Aggregation Through Stabilizers And Surfactants 1/13/2025

    Learn about protein aggregation mechanisms, the role of excipients in stabilization, and novel surfactants that prevent aggregation in therapeutic protein formulations in this webinar.

  6. The Crucial Role Of Apheresis In Cellular Therapies 1/8/2025

    Gain valuable insights into the critical role of apheresis in sourcing high-quality cellular material for therapies.

  7. Exploring New And Improved Analytical Methods For Traditional And Unique Modalities 1/2/2025

    Here, we review several challenges in biologics analysis and take a closer look at the advanced tools and methods being utilized to improve biophysical analysis reliability and efficiency.

  8. BioPhorum Raw Materials Risk Assessments 12/19/2024

    Torsten Schaderdorf provides an in-depth exploration of current regulations related to Raw Materials Risk Assessment, highlighting the risk criteria and raw material scope outlined in the BioPhorum guidelines.

  9. Assemblies Are Not Particulate Free, Strategies For Risk Mitigation 12/19/2024

    As single-use technologies gain prominence in critical applications, the scrutiny around particulate contamination intensifies due to its potential impact on drug product quality, safety, and patient outcomes.

  10. Transforming The Biopharma Supply Chain, eData Solutions For Agility And Manufacturing Efficiency 12/19/2024

    Explore the role of eData in automating processes, enabling predictive analytics, improving supply chain resilience, and adopting standardized digital platforms in biopharma manufacturing.